✦ LIBER ✦

Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease

✍ Scribed by Meijer, Esther; Drenth, Joost P.H.; d'Agnolo, Hedwig; Casteleijn, Niek F.; de Fijter, Johan W.; Gevers, Tom J.; Kappert, Peter; Peters, Dorien J.M.; Salih, Mahdi; Soonawala, Darius; Spithoven, Edwin M.; Torres, Vicente E.; Visser, Folkert W.; Wetzels, Jack F.M.; Zietse, Robert; Gansevoort, Ron T.

Book ID: 123383378
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 255 KB
Volume: 63
Category: Article
ISSN: 0272-6386
DOI: 10.1053/j.ajkd.2013.10.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and design of the RESOLVE tria

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease

✍ Gevers, Tom JG; Chrispijn, Melissa; Wetzels, Jack FM; Drenth, Joost PH 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 164 KB

Rationale and Design of the TEMPO (Tolva

Rationale and Design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and Its Outcomes) 3-4 Study

✍ Vicente E. Torres; Esther Meijer; Kyongtae T. Bae; Arlene B. Chapman; Olivier De 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 418 KB

201 RATIONALE AND DESIGN OF THE PARKFIT

201 RATIONALE AND DESIGN OF THE PARKFIT STUDY: A RANDOMIZED CONTROLLED TRIAL TO INCREASE PHYSICAL ACTIVITY IN PATIENTS WITH PARKINSON'S DISEASE

✍ A. Speelman; M. van Nimwegen; K. Smulders; S. Overeem; G. Borm; F. Backx; B. Blo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

The MINERVA study design and rationale:

The MINERVA study design and rationale: A controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias

✍ Reinhard C. Funck; Giuseppe Boriani; Antonis S. Manolis; Helmut Püererfellner; L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 241 KB

The ACTonHEART study: rationale and desi

The ACTonHEART study: rationale and design of a randomized controlled clinical trial comparing a brief intervention based on Acceptance and Commitment Therapy to usual secondary prevention care of coronary heart disease

✍ Spatola, Chiara AM; Manzoni, Gian; Castelnuovo, Gianluca; Malfatto, Gabriella; F 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 239 KB

Rationale, design, and baseline characte

Rationale, design, and baseline characteristics of the Study assessInG the morbidity-mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease (SIGNIFY trial): A randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical heart failure

✍ Fox, Kim; Ford, Ian; Steg, Philippe Gabriel; Tardif, Jean-Claude; Tendera, Micha 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 459 KB